AbbVie Inc. — Director's Dealing 2022

May 18, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2022-05-16

Reporting Person: Gosebruch Henry O (EVP, Chief Strategy Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-16	Common Stock, $0.01 par value	M	83960	$54.86	Acquired	100583	Direct
2022-05-16	Common Stock, $0.01 par value	S	83960	$155.00	Disposed	16623	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-05-16	Option (Right to Buy)	$54.86	M	83960	Disposed	2026-02-17	Common Stock (83960)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $0.01 par value	78500	Indirect
Common Stock, $0.01 par value	3457	Indirect

Footnotes

F1: The reporting person is trustee of a trust established for the benefit of his children. The reporting person disclaims beneficial ownership of all securities held by the trust.

F2: Balance in AbbVie Savings program as of January 31, 2022.

F3: Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.